![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom
Received July 14, 2005; accepted November 23, 2005
| Abstract |
|---|
|
|
|---|
1 and -
2) and neurofilament light peptide (NF-L) were found to be characteristic of the aging process as reported in vivo (Brain Res 907:71-83, 2001[CrossRef][Medline]; Brain Res Mol Brain Res 99:40-45, 2002[Medline]). In contrast, the genes for the controlling enzymes of heme synthesis and degradation (5-aminolevulinate synthase 1 and heme oxygenase 1, respectively) were up-regulated, implying depletion of a regulatory heme pool. Inhibition of heme synthesis (by 70-80%) at different enzymic steps by succinyl acetone and N-methylprotoporphyrin IX resulted in the earlier lowered expression of NMDA
1 and -
2 and NF-L. Exogenous hemin added to heme-depleted cells rescued the expression of these neuron-specific genes. Culture of cortical neurons from BALB/c Fechm1Pas mutant mice demonstrating depressed heme synthesis showed premature senescence and reduced expression of NMDA
1 and -
2 receptor subunits and NF-L compared with wild-type cells. Our findings suggest that reduced availability of heme in neurons associated with senescence may have significant effects on synaptic function.
in Alzheimer's disease may be an additional limitation on its availability (Atamna and Frey, 2004
1 and
2, which are important for learning and memory (Eckles-Smith et al., 2000
In this study, we established that cultures of primary cortical neurons exhibited increasing senescence and up-regulation of the genes for ALAS1 and HMOX1, suggesting a state of relative heme deficiency and down-regulation of expression of the neuron-specific genes for NMDA receptor subunits
1 and
2. A relationship between expression of NMDA receptor subunits and heme synthesis was confirmed with inhibitor and mutant models of heme depletion and restored by exogenous heme.
| Materials and Methods |
|---|
|
|
|---|
Inhibition and Measurement of Heme Synthesis. To inhibit heme synthesis, cells were cultured in serum-free medium with 0.5 mM succinyl acetone (Sigma-Aldrich, Dorset, UK) or with 1 µM N-methylprotoporphyrin IX (Frontier Scientific Porphyrin Products, Logan, UT) continuously for the duration of the experiments. For measurement of heme synthesis, cells were incubated with 0.4 µCi of [3,5-3H]ALA (2.6 Ci/mmol; PerkinElmer, Boston, MA) for 24 h. Heme was extracted from the cells by acetone-HCl and diethyl ether. The amount of radioactivity in extracted heme was measured by liquid scintillation counting as described previously (Shedlofsky et al., 1987
). Total recovery of radioactivity from all fractions was the same for treated and untreated cells. Ferrochelatase activity of cortical tissue was measured as reported for lymphocytes (Rossi et al., 1988
). For heme recovery experiments, heme as hemin (0.1 µM) was added to culture medium in the presence of bovine serum albumin in a 1:1 M ratio (Taketani et al., 1998
).
Necrosis, Apoptosis, and Senescence. Cell viability in heme depletion experiments was estimated by using SYTOX/Hoechst double-staining method. To determine the amount of necrosis or apoptosis in the neurons, the cultures were stained with a mixture of the membrane-permeable dye Hoechst-33342 (500 ng/ml) and the membrane-impermeable dye SYTOX (500 nM) for 5 min at 37°C. The amount of normal, necrotic (damaged/SYTOX-permeable membrane, normal nuclei) and apoptotic (impermeable membrane, condensed/fragmented nuclei) cells were scored with a fluorescence microscope and no significant difference was observed at any time between controls and any of the treatments performed in this study. Identification of senescent cells was performed with Senescent Cells Staining Kit (Sigma-Aldrich) in accordance with manufacturer's instructions by detection of
-galactosidase histochemically at pH 6 (Dimri et al., 1995
).
RNA Extraction and Quantitative Real-Time PCR Analysis. Treated and untreated cells from different time points were collected, and total RNA was isolated by using TRI-reagent (Sigma-Aldrich). cDNA synthesis was carried out using random primers and Superscript II (Invitrogen). PCR primers were selected using the Primer Express v2.0 Software program (Applied Biosystems, Foster City, CA).
Primer sequences are shown in Table 1. Primers were designed to cross exon-exon boundaries and the concentration optimized (300-900 nM) to ensure that the efficiency of the target amplification and the efficiency of the endogenous reference amplification are approximately equal. PCR was performed using SYBR Green PCR Master Mix, primers, and 100 ng of reverse-transcribed cDNA in the PRISM 7700 Sequence Detection System (Applied Biosystems). The thermal-cycler protocol was: stage 1, 50°C for 2 min; stage 2, 95°C for 10 min; and stage 3, 40 cycles at 95°C for 15 s and 60°C for 1 min. Each sample was run in triplicate. The CT (threshold cycle when fluorescence intensity exceeds 10 times the S.D. of the baseline fluorescence) values for the target amplicon and endogenous control (
2-microglobulin or
-actin) were determined for each sample. Quantification was performed using the comparative CT method (
CT). Data are presented as the mean ± S.D. (n = 3-7 for each group). Statistical significance was assessed as P < 0.05 using one-way analysis of variance.
|
Immunoblotting. Proteins were extracted from primary neurons after 14 and 21 days of culture using lysis buffer (7 M urea, 50 mM Tris-HCl, pH 7.5, and 5 mM dithiothreitol) followed by brief sonication. SDS electrophoresis and immunoblotting were performed (Davies et al., 2005
) using chemiluminescence detection (ECL; Amersham Pharmacia, Buckinghamshire, UK) and primary antibodies from the following sources: HMOX1 AND HMOX2 from Stressgen (Victoria, BC, Canada), NMDA
1, neurofilament light polypeptide (NF-L), and
-tubulin from Santa Cruz Biotechnology (Santa Cruz, CA). Results were quantified using densitometry and ImageQuant 5.2 software (GE Healthcare, Little Chalfont, Buckinghamshire, UK). Statistical significance of data was estimated using two-tailed student's t test.
| Results |
|---|
|
|
|---|
-Galactosidase activity detected by histochemical staining is a measure of increased residual lysosomal activity at a suboptimal pH and has been used to identify senescent human cells in culture and in vivo (Dimri et al., 1995
The proportion of the senescent cells steadily increased in neuron cultures (Figs. 1, A-C, and 2A). We also detected a significant increase in cathepsin L expression over time (Fig. 2B). Up-regulation of proteases such as cathepsin L is associated with the development of senescence phenotypes causing a disruption of tissue integrity and function (Varela et al., 2005
). The proportion of cells detected showing apoptosis and necrosis was not significantly changed during this time.
|
|
|
1 and
2 and NF-L that had recovered from plating and were induced to the greatest level on day 14 (Fig. 3, D-F) reflecting maximum neurite networking. For instance, an increase in NMDA
1 mRNA was observed from day 2 and, by day 14, reached a significant maximum of 22-fold but declined to only 5-fold higher on day 25. Complementary changes in HMOX1, HMOX2, and NMDA
1 protein expression were demonstrated by immunoblotting (Fig. 3G). Thus, lower expression of the genes associated with neurons was associated with aging of the cells and inversely related to up-regulation of the genes for ALAS1 and HMOX1. NMDA
2 temporal expression pattern was similar to that of NMDA
1 but with changes that were less marked.
Heme Deficiency Results in Down-Regulation of Neuron-Specific Genes. To test whether heme deficiency per se could effect neuronal gene expression, cells were treated continuously with succinyl acetone (SA), a specific inhibitor of ALA dehydratase (Tschudy et al., 1981
), or NMP, a specific inhibitor of ferrochelatase (De Matteis and Marks, 1996
). Heme synthesis in cultures was significantly depressed by both treatments (Fig. 4A). On days 12 and 18 of culture in the presence of SA, ALAS1 expression was significantly higher than in control cells (Fig. 4, B and C). The expression of HMOX1 was similarly induced, although no difference between heme-depleted and control cells was observed in the expression of constitutive HMOX2. Increased HMOX1 protein, but not HMOX2, was confirmed by Western blotting (Fig. 4E). Inhibition of heme synthesis by NMP resulted in similar changes in ALAS1 and HMOX1 expressions (Fig. 4D). In contrast, in both heme-depleted cultures, expression of NMDA receptor subunits
1 and
2 and NF-L were significantly depressed compared with neurons not exposed to SA or NMP (Fig. 5). By day 18, when the control culture was also displaying signs of aging, expression of NF-L was detected at similar levels in treated and untreated neurons. A similar pattern but with more profound changes was detected in NMP-treated cells (Fig. 5D). Thus, disruption of heme synthesis with SA and NMP resulted in premature changes in expression of genes associated with aging of untreated cells.
|
|
Protection by Heme. Neurons treated with SA to depress heme synthesis were cocultured with heme at a level (0.1 µM as hemin) added in albumin thought to balance heme synthesis without inducing heme degradation (Taketani et al., 1998
; Sassa, 2004
). As shown in Fig. 4B, SA induced upregulation of the genes for ALAS1 and HMOX1 and down-regulation of NMDA
1 and NMDA
2. In the presence of additional heme, this was mostly reversed so that only small changes in expression of NMDA
1 and NMDA
2 were observed and ALAS1 and HMOX1 were little affected (Fig. 6, A-D). To compare this finding with the effect of heme deficiency on an inhibitory neurotransmitter type receptor, we investigated the expression of the GABAA receptor. The most common receptor configuration includes the
1 subunit (Wassef et al., 2003
). We did not detect marked changes in the expression of GABAA
1 in SA-treated neurons, and additional heme did not alter expression of the gene (Fig. 6E).
|
-galactosidase activity showed earlier signs of senescence compared with control BALB/c neurons so that by day 12, 89.1 ± 3.2% (n = 5) of the Fech cells were identified as senescent (Fig. 1D), whereas this degree of senescence was not observed until much later with control BALB/c cells.
|
1 expression in Fech neurons was less than 20% of that in a control culture on day 6 and 30% on day 14. NMDA
2 detected in Fech neurons was 57% and 53% on days 6 and 14 of culture, respectively, compared with the wild-type cells. Treatment with exogenous heme (0.1 µM hemin) largely rescued expression of MNDA
1 in Fech neurons (Fig. 6F). | Discussion |
|---|
|
|
|---|
1 and -
2 subunit expressions seemed to be directly associated with aging of the cortical neurons after initial differentiation. The decline of expressions of NMDA receptor subunits NMDA
1 and -
2 (NR1 and NR2A in the rat; NMDA1 and NMDA2 in humans) in an age-dependent manner in vivo is well established and may also have effects on agonist and antagonist binding to the intact receptor (Eckles-Smith et al., 2000
1 over time.
In sharp contrast to genes associated with neuronal function, expression of genes associated with control of heme synthesis and catabolism (those for ALAS1 and HMOX1) were markedly induced in older cultures of neurons on day 21 and longer, by which time the proportion of senescent neurons in cultures was estimated at approximately 86%. Alas1, the gene for the rate-controlling enzyme of nonerythroid heme synthesis, is usually considered to be up-regulated in liver by repression of a negative feedback mechanism as a consequence of a depleted regulatory heme pool (Sassa and Nagai, 1996
). Our findings agree with in vivo studies that this mechanism probably also operates in the brain (De Matteis et al., 1981
; De Matteis and Ray, 1982
). Up-regulation of Alas1 in neurons may be evidence of limitation of heme supply with aging of the cells. This was probably compounded by the simultaneous greater expression of the heme-degrading enzyme HMOX1, which is often associated with conditions of cellular stress and may be an attempt to generate the antioxidant bilirubin as well as the signaling molecule CO (Sassa, 2004
). However, this mechanism must depend on the synthesis of considerable amounts of extra heme as a substrate in addition to that required for normal cellular functions, because little free heme is likely to be available for this purpose in cells (Sassa, 2004
). Elevated activity of heme oxygenases may exacerbate a problem, already present, of inadequate heme supply in aging cells.
Although the changes in older culture of primary neurons were consistent with heme depletion partly associated with induction of HMOX1, and also a decline in expression of NMDA receptor subunit genes, it was not clear whether there was any link between these systems. To address this point, differentiating cultures of neurons displaying maximum expression of NMDA subunits were treated with SA or NMP to inhibit different steps in heme synthesis, thereby potentially producing heme-depleted cells (De Matteis et al., 1981
; Tschudy et al., 1981
; Sassa and Nagai, 1996
). Treated cells did indeed show significantly depressed heme synthesis, with patterns of Alas1 and Hmox1 up-regulation observed in much older cultures of untreated cells. In contrast, there was decreased expression of NMDA receptor subunits and NF-L, especially with NMP. This could be considered premature aging of the primary neurons and seemed to indicate that there could be a direct relationship between heme supply and the expression of these neuron-specific genes. We were unable to exclude from this the possibility that SA or NMP might inherently affect gene expression or some other process that might influence that of the subunits of NMDA receptor. However, when heme was added back at physiologically relevant levels to SA-treated cells, expression of the Alas1 and Hmox1 genes was decreased and expression of those for NMDA receptor subunits was mostly restored.
The use of primary cortical neurons from Fech mice obviated the need for chemical intervention to cause a depleted heme supply (Tutois et al., 1991
). This allowed investigation of whether 1) up-regulation of HMOX1 in a stressed environment was the primary event with subsequent up-regulation of Alas1 or 2) heme depletion per se occurred first and was compounded by induction of HMOX1 activity as cells aged. Not only was Alas1 up-regulated to a greater degree in Fech primary culture than in wild-type BALB/c cells at any time point as a result of defective heme synthesis but also neurons displayed signs of premature senescence. Modest induction of HMOX1 expression in Fech embryonic cells was possibly associated with providing defense against oxidative stress but at the same time enhancing the potential for heme depletion. It is noteworthy that after an initial increased expression compared with that in BALB/c cells, NMDA receptor genes, especially for NMDA
1, were expressed significantly less and suggest that heme itself could affect expression of these neuron-specific genes. An interesting finding of different effect of heme deficiency on GABA neurotransmitter receptor subunit and glutamate receptor NMDA subunit may lead to better understanding of why heme-distorted metabolism results in certain clinical manifestations in patients. One of the possible explanations of this distinctive difference in effects for NMDA and GABA receptors could be related to regulation by different signaling pathways (Zhu et al., 2002
; Kumar et al., 2005
).
What could be the mechanism of the senescence of cortical neurons being affected by heme supply? Studies of human brain cell lines have shown that inhibitors of heme synthesis can activate NO synthesis and alter zinc and iron metabolism and that cells fail to differentiate or undergo a successful cell cycle (Atamna et al., 2002
). This might be due in part to a decrease in mitochondrial function, especially complex IV, as a consequence of specific disruption in the synthesis of heme a. However, hepatic mitochondrial respiratory chain activities, including complex IV (cytochrome oxidase), remained unchanged or were increased in Fech mice (Navarro et al., 2005
). Observations of neurite outgrowth have indicated that heme may act by regulation of kinases concerned with structural proteins and receptors (Ishii and Maniatis, 1978
). It is interesting that inhibition of heme synthesis interferes with neuron growth factor-induced outgrowth of PC-12 cells by diminishing a subset of neuron-specific genes expressed via the Ras-mitogen activated protein kinase signaling pathway, including NF-L (Zhu et al., 2002
; Sengupta et al., 2005
).
In summary, long-term primary cultures of mouse cortical neurons displayed senescence, decreased expression of NMDA receptor subunits, and characteristics of heme deficiency, as have been observed in vivo for aging. Down-regulation of NMDA receptor subunit expression was potentiated by both inhibitor and mutant models of heme depletion, strongly suggesting a mechanistic link between these metabolic processes.
| Acknowledgements |
|---|
| Footnotes |
|---|
ABBREVIATIONS: HMOX, heme oxygenase; ALAS, aminolevulinate synthase; NMDA, N-methyl-D-aspartate; CT, threshold cycle; NF-L, neurofilament light polypeptide; PCR, polymerase chain reaction; RT, reverse transcription; SA, succinyl acetone; NMP, N-methylprotoporphyrin IX.
Address correspondence to: Dr. Tatyana Chernova, MRC Toxicology Unit, University of Leicester, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK. E-mail: tc28{at}le.ac.uk
| References |
|---|
|
|
|---|
Atamna H, Killilea DW, Killilea AN, and Ames BN (2002) Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci USA 99: 14807-14812.
Bitar MS and Shapiro BH (1987) Aberration of heme and hemoprotein in aged female rats. Mech Ageing Dev 38: 189-197.[CrossRef][Medline]
Boehning D and Snyder SH (2003) Novel neural modulators. Annu Rev Neurosci 26: 105-131.[CrossRef][Medline]
Campisi J (2005) Aging, tumor suppression and cancer: high wire-act! Mech Ageing Dev 126: 51-58.[CrossRef][Medline]
Davies R, Schuurman A, Barker CR, Clothier B, Chernova T, Higginson FM, Judah DJ, Dinsdale D, Edwards RE, Greaves P, et al. (2005) Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. Am J Pathol 166: 1041-1053.
De Matteis F and Marks GS (1996) Cytochrome P450 and its interactions with the heme biosynthetic pathway. Can J Physiol Pharmacol 74: 1-8.[CrossRef][Medline]
De Matteis F and Ray DE (1982) Studied on cerebellar haem metabolism in the rat in vivo. J Neurochem 39: 551-556.[CrossRef][Medline]
De Matteis F, Zetterlund P, and Wetterberg L (1981) Brain 5-aminolaevulinate synthase: developmental aspects and evidence for regulatory role. Biochem J 196: 811-817.[Medline]
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
Eckles-Smith K, Clayton D, Bickford P, and Browning MD (2000) Caloric restriction prevents age-related deficits in LTP and in NMDA receptor expression. Brain Res Mol Brain Res 78: 154-162.[Medline]
Goldstein L, Teng ZP, Zeserson E, Patel M, and Regan RF (2003) Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J Neurosci Res 73: 113-121.[CrossRef][Medline]
Ingi T, Chiang G, and Ronnett GV (1996) The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. J Neurosci 16: 5621-5628.
Ishii DN and Maniatis GM (1978) Haemin promotes rapid neurite outgrowth in cultured mouse neuroblastoma cells. Nature (Lond) 274: 372-374.[CrossRef][Medline]
Kaasik K and Lee CC (2004) Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature (Lond) 430: 467-471.[CrossRef][Medline]
Kumar S, Khisti RT, and Morrow AL (2005) Regulation of native GABA(A) receptors by PKC and protein phosphatase activity. Psychopharmacology (Berl) 183: 241-247.[CrossRef][Medline]
Kurz DJ, Decary S, Hong Y, and Erusalimsky JD (2000) Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 113 (Pt 20): 3613-3622.[Abstract]
Lindberg RL, Martini R, Baumgartner M, Erne B, Borg J, Zielasek J, Ricker K, Steck A, Toyka KV, and Meyer UA (1999) Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. J Clin Investig 103: 1127-1134.[Medline]
Magnusson KR, Nelson SE, and Young AB (2002) Age-related changes in the protein expression of subunits of the NMDA receptor. Brain Res Mol Brain Res 99: 40-45.[Medline]
Meyer RP, Podvinec M, and Meyer UA (2002) Cytochrome P450 CYP1A1 accumulates in the cytosol of kidney and brain and is activated by heme. Mol Pharmacol 62: 1061-1067.
Navarro S, Del Hoyo P, Campos Y, Abitbol M, Moran-Jimenez MJ, Garcia-Bravo M, Ochoa P, Grau M, Montagutelli X, Frank J, et al. (2005) Increased mitochondrial respiratory chain enzyme activities correlate with minor extent of liver damage in mice suffering from erythropoietic protoporphyria. Exp Dermatol 14: 26-33.[CrossRef][Medline]
Nicotera P (2003) Molecular switches deciding the death of injured neurons. Toxicol Sci 74: 4-9.
Ogawa K, Sun J, Taketani S, Nakajima O, Nishitani C, Sassa S, Hayashi N, Yamamoto M, Shibahara S, Fujita H, et al. (2001) Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO (Eur Mol Biol Organ) J 20: 2835-2843.[CrossRef][Medline]
Ossowska K, Wolfarth S, Schulze G, Wardas J, Pietraszek M, Lorenc-Koci E, Smialowska M, and Coper H (2001) Decline in motor functions in aging is related to the loss of NMDA receptors. Brain Res 907: 71-83.[CrossRef][Medline]
Paterniti JR Jr, Lin CI, and Beattie DS (1978) delta-Aminolevulinic acid synthetase: regulation of activity in various tissues of the aging rat. Arch Biochem Biophys 191: 792-797.[CrossRef][Medline]
Rank JM, Carithers R, and Bloomer J (1993) Evidence for neurological dysfunction in end-stage protoporphyric liver disease. Hepatology 18: 1404-1409.[CrossRef][Medline]
Rossi E, Costin KA, and Garcia-Webb P (1988) Ferrochelatase activity in human lymphocytes, as quantified by a new high-performance liquid-chromatographic method. Clin Chem 34: 2481-2485.
Sangerman J, Killilea A, Chronister R, Pappolla M, and Goodman SR (2001) Alpha-spectrins are major ubiquitinated proteins in rat hippocampal neurons and components of ubiquitinated inclusions in neurodegenerative disorders. Brain Res Bull 54: 405-411.[CrossRef][Medline]
Sassa S (2004) Why heme needs to be degraded to iron, biliverdin IXalpha and carbon monoxide? Antioxid Redox Signal 6: 819-824.[Medline]
Sassa S and Nagai T (1996) The role of heme in gene expression. Int J Hematol 63: 167-178.[CrossRef][Medline]
Sengupta A, Hon T, and Zhang L (2005) Heme deficiency suppresses the expression of key neuronal genes and causes neuronal cell death. Brain Res Mol Brain Res 137: 23-30.[Medline]
Shedlofsky SI, Sinclair PR, Bonkovsky HL, Healey JF, Swim AT, and Robinson JM (1987) Haem synthesis from exogenous 5-aminolaevulinate in cultured chickembryo hepatocytes. Effects of inducers of cytochromes P-450. Biochem J 248: 229-236.[Medline]
Taketani S, Immenschuh S, Go S, Sinclair PR, Stockert RJ, Liem HH, and Muller Eberhard U (1998) Hemopexin from four species inhibits the association of hem with cultured hepatoma cells or primary rat hepatocytes exhibiting a small number of species specific hemopexin receptors. Hepatology 27: 808-814.[CrossRef][Medline]
Taoka S, Lepore BW, Kabil O, Ojha S, Ringe D, and Banerjee R (2002) Human cystathionine beta-synthase is a heme sensor protein. Evidence that the redox sensor is heme and not the vicinal cysteines in the CXXC motif seen in the crystal structure of the truncated enzyme. Biochemistry 41: 10454-10461.[CrossRef][Medline]
Tschudy DP, Hess RA, and Frykholm BC (1981) Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid. J Biol Chem 256: 9915-9923.
Tutois S, Montagutelli X, Da Silva V, Jouault H, Rouyer-Fessard P, Leroy-Viard K, Guenet JL, Nordmann Y, Beuzard Y, and Deybach JC (1991) Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity and liver disease. J Clin Investig 88: 1730-1736.[Medline]
Uylings HB and de Brabander JM (2002) Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn 49: 268-276.[CrossRef][Medline]
Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM, Zhou Z, Rodriguez FJ, Stewart CL, Vega JA, et al. (2005) Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature (Lond) 437: 564-568.[CrossRef][Medline]
Wassef A, Baker J, and Kochan LD (2003) GABA and schizophrenia: a review of basic science and clinical studies. J Clin Psychopharmacol 23: 601-640.[CrossRef][Medline]
Zhu YHT, Ye W, and Zhang L (2002) Heme deficiency interferes with the Ras-mitogen-activated protein kinase signaling pathway and expression of a subset of neuronal genes. Cell Growth Differ 13: 431-439.
This article has been cited by other articles:
![]() |
T. Chernova, J. R. Steinert, C. J. Guerin, P. Nicotera, I. D. Forsythe, and A. G. Smith Neurite Degeneration Induced by Heme Deficiency Mediated via Inhibition of NMDA Receptor-Dependent Extracellular Signal-Regulated Kinase 1/2 Activation J. Neurosci., August 8, 2007; 27(32): 8475 - 8485. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Atamna, J. Newberry, R. Erlitzki, C. S. Schultz, and B. N. Ames Biotin Deficiency Inhibits Heme Synthesis and Impairs Mitochondria in Human Lung Fibroblasts J. Nutr., January 1, 2007; 137(1): 25 - 30. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||